DHT selectively reverses Smad3-mediated/TGF-β-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells

Molecular Endocrinology

Volumn 24, Issue 10, 2010, Pages 2019-2029

  Song, Kyung ^a   Wang, Hui ^a   Krebs, Tracy L ^a   Wang, Bingcheng ^a,b   Kelley, Thomas J ^a   Danielpour, David ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROSTANOLONE; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CASTRATION; CELL PROLIFERATION; CELL PROTECTION; CELL STRAIN LNCAP; CONTROLLED STUDY; CYTOMEGALOVIRUS; DOWN REGULATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTROSPECTION; MALE; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; DIHYDROTESTOSTERONE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; MALE; PROSTATE; RATS; RECEPTORS, ANDROGEN; SMAD3 PROTEIN; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

CYTOMEGALOVIRUS;

EID: 77957345152     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2010-0165     Document Type: Article

References (52)

1. Roberts AB, Sporn MB 1990 The transforming growth factor β. New York: Springer-Verlag
2. Roberts AB, Wakefield LM 2003 The two faces of transforming growth factor β in carcinogenesis. Proc Natl Acad Sci USA 100:8621-8623
3. Wrana JL, Attisano L 2000 The Smad pathway. Cytokine Growth Factor Rev 11:5-13
4. Massagué J, Chen YG 2000 Controlling TGF-β signaling. Genes Dev 14:627-644
5. Itoh S, ten Dijke P 2007 Negative regulation of TGF-β receptor/Smad signal transduction. Curr Opin Cell Biol 19:176-184
6. Chipuk JE, Cornelius SC, Pultz NJ, Jorgensen JS, Bonham MJ, Kim SJ, Danielpour D 2002 The androgen receptor represses transforming growth factor-β signaling through interaction with Smad3. J Biol Chem 277:1240-1248
7. Danielpour D, Song K 2006 Cross-talk between IGF-I and TGF-β signaling pathways. Cytokine Growth Factor Rev 17:59-74 (Pubitemid 43117516)
8. Song K, Krebs TL, Danielpour D 2006 Novel permissive role of epidermal growth factor in transforming growth factor β (TGF-β) signaling and growth suppression. Mediation by stabilization of TGF-β receptor type II. J Biol Chem 281:7765-7774 (Pubitemid 43847390)
9. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GG, Jenster G, Trapman J, Brinkmann AO, Mulder E 1992 The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristics and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669
10. Ohara-Nemoto Y, Nemoto T, Sato N, Ota M 1988 Characterization of the nontransformed and transformed androgen receptor and heat shock protein 90 with high-performance hydrophobic-interaction chromatography. J Steroid Biochem 31:295-304
11. Heinlein CA, Chang C 2002 Androgen receptor (AR) coregulators: an overview. Endocr Rev 23:175-200
12. Heinlein CA, Chang C 2004 Androgen receptor in prostate cancer. Endocr Rev 25:276-308
13. Burd CJ, Morey LM, Knudsen KE 2006 Androgen receptor corepressors and prostate cancer. Endocr Relat Cancer 13:979-994 (Pubitemid 46212560)
14. Kang HY, Lin HK, Hu YC, Yeh S, Huang KE, Chang C 2001 From transforming growth factor-β signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells. Proc Natl Acad Sci USA 98:3018-3023 (Pubitemid 32220792)
15. Kang HY, Huang KE, Chang SY, Ma WL, Lin WJ, Chang C 2002 Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4. J Biol Chem 277:43749-43756 (Pubitemid 36157793)
16. Song K, Wang H, Krebs TL, Kim SJ, Danielpour D 2008 Androgenic control of transforming growth factor-β signaling in prostate epithelial cells through transcriptional suppression of transforming growth factor-β receptor II. Cancer Res 68:8173-8182
17. Hayes SA, Zarnegar M, Sharma M, Yang F, Peehl DM, ten Dijke P, Sun Z 2001 SMAD3 represses androgen receptor-mediated transcription. Cancer Res 61:2112-2118
18. Placencio VR, Sharif-Afshar AR, Li X, Huang H, Uwamariya C, Neilson EG, Shen MM, Matusik RJ, Hayward SW, Bhowmick NA 2008 Stromal transforming growth factor-β signaling mediates prostatic response to androgen ablation by paracrine Wnt activity. Cancer Res 68:4709-4718
19. Kyprianou N, Isaacs JT 1989 Expression of transforming growth factor-β in the rat ventral prostate during castration-induced programmed cell death. Mol Endocrinol 3:1515-1522 (Pubitemid 19260400)
20. Kim IY, Ahn HJ, Zelner DJ, Park L, Sensibar JA, Lee C 1996 Expression and localization of transforming growth factor-β receptors type I and type II in the rat ventral prostate during regression. Mol Endocrinol 10:107-115 (Pubitemid 26023778)
21. Brodin G, ten Dijke P, Funa K, Heldin CH, Landström M 1999 Increased smad expression and activation are associated with apoptosis in normal and malignant prostate after castration. Cancer Res 59:2731-2738
22. Desai KV, Kondaiah P 2000 Androgen ablation results in differential regulation of transforming growth factor-β isoforms in rat male accessory sex organs and epididymis. J Mol Endocrinol 24:253-260 (Pubitemid 30187055)
23. Danielpour D 2005 Functions and regulation of transforming growth factor-β (TGF-β) in the prostate. Eur J Cancer 41:846-857 (Pubitemid 40461689)
24. Kundu SD, Kim IY, Yang T, Doglio L, Lang S, Zhang X, Buttyan R, Kim SJ, Chang J, Cai X, Wang Z, Lee C 2000 Absence of proximal duct apoptosis in the ventral prostate of transgenic mice carrying the C3(1)-TGF-β type II dominant negative receptor. Prostate 43:118-124 (Pubitemid 30220614)
25. Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D 1998 The role of transforming growth factor-β1, -β2, and -β3 in androgen- responsive growth of NRP-152 rat prostatic epithelial cells. J Cell Physiol 175:184-192 (Pubitemid 28140675)
26. Zhu ML, Partin JV, Bruckheimer EM, Strup SE, Kyprianou N 2008 TGF-β signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells. Prostate 68:287-295
27. van der Poel HG 2005 Androgen receptor and TGFβ1/Smad signaling are mutually inhibitory in prostate cancer. Eur Urol 48:1051-1058
28. Hsing AY, Kadomatsu K, Bonham MJ, Danielpour D 1996 Regulation of apoptosis induced by transforming growth factor-β1 in nontumorigenic rat prostatic epithelial cell lines. Cancer Res 56:5146-5149
29. Yang J, Song K, Krebs TL, Jackson MW, Danielpour D 2008 Rb/ E2F4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression. Oncogene 27:5326-5338
30. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW 2000 LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate 44:91-103 (Pubitemid 30419183)
31. Korenchuk S, Lehr JE, Mclean L, Lee YG, Whitney S, Vessella R, Lin DL, Pienta KJ 2001 VCaP, a cell-based model system of human prostate cancer. In Vivo 15:163-168 (Pubitemid 32328191)
32. Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH 2004 Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J Clin Oncol 22:2790-2799 (Pubitemid 41079896)
33. Baybis M, Yu J, Lee A, Golden JA, Weiner H, McKhann II G, Aronica E, Crino PB 2004 mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol 56:478-487 (Pubitemid 39319337)
34. Lee JY, Elmer HL, Ross KR, Kelley TJ 2004 Isoprenoid-mediated control of SMAD3 expression in a cultured model of cystic fibrosis epithelial cells. Am J Respir Cell Mol Biol 31:234-240
35. Yang J, Wahdan-Alaswad R, Danielpour D 2009 Critical role of Smad2 in tumor suppression and transforming growth factor-β- induced apoptosis of prostate epithelial cells. Cancer Res 69:2185-2190
36. Qi W, Gao S, Wang Z 2008 Transcriptional regulation of the TGF-β1 promoter by androgen receptor. Biochem J 416:453-462
37. Nishi N, Oya H, Matsumoto K, Nakamura T, Miyanaka H, Wada F 1996 Changes in gene expression of growth factors and their receptors during castration-induced involution and androgen-induced regrowth of rat prostates. Prostate 28:139-152 (Pubitemid 26110734)
38. Wang H, Song K, Krebs TL, Yang J, Danielpour D 2008 Smad7 is inactivated through a direct physical interaction with the LIM protein Hic-5/ARA55. Oncogene 27:6791-6805
39. English HF, Santen RJ, Isaacs JT 1987 Response of glandular versus basal rat ventral prostatic epithelial cells to androgen withdrawal and replacement. Prostate 11:229-242
40. Prins GS, Birch L, Greene GL 1991 Androgen receptor localization in different cell types of the adult rat prostate. Endocrinology 129:3187-3199
41. Danielpour D 1999 Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-I and transforming growth factor-β. J Cell Sci 112:169-179.
42. Bonkhoff H, Stein U, Remberger K 1994 Multidirectional differentiation in the normal, hyperplastic, and neoplastic human prostate: simultaneous demonstration of cell-specific epithelial markers. Hum Pathol 25:42-46
43. Bonkhoff H, Stein U, Remberger K 1994 The proliferative function of basal cells in the normal and hyperplastic human prostate. Prostate 24:114-118
44. Curtin D, Jenkins S, Farmer N, Anderson AC, Haisenleder DJ, Rissman E, Wilson EM, Shupnik MA 2001 Androgen suppression of GnRH-stimulated rat LHβ gene transcription occurs through Sp1 sites in the distal GnRH-responsive promoter region. Mol Endocrinol 15:1906-1917
45. Milanini-Mongiat J, Pouysségur J, Pagès G 2002 Identification of two Sp1 phosphorylation sites for p42/p44 mitogen-activated protein kinases: their implication in vascular endothelial growth factor gene transcription. J Biol Chem 277:20631-20639
46. Banchio C, Schang LM, Vance DE 2004 Phosphorylation of Sp1 by cyclin-dependent kinase 2 modulates the role of Sp1 in CTP:phosphocholine cytidylyltransferase α regulation during the S phase of the cell cycle. J Biol Chem 279:40220-40226 (Pubitemid 39258298)
47. Litvinov IV, Vander Griend DJ, Antony L, Dalrymple S, De Marzo AM, Drake CG, Isaacs JT 2006 Androgen receptor as a licensing factor for DNA replication in androgen-sensitive prostate cancer cells. Proc Natl Acad Sci USA 103:15085-15090 (Pubitemid 44583168)
48. Heemers HV, Regan KM, Schmidt LJ, Anderson SK, Ballman KV, Tindall DJ 2009 Androgen modulation of coregulator expression in prostate cancer cells. Mol Endocrinol 23:572-583
49. Chen Y, Sawyers CL, Scher HI 2008 Targeting the androgen receptor pathway in prostate cancer. Curr Opin Pharmacol 8:440-448
50. Danielpour D, Kadomatsu K, Anzano MA, Smith JM, Sporn MB 1994 Development and characterization of nontumorigenic and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 54:3413-3421 (Pubitemid 24225960)
51. Bonham MJ, Danielpour D 1996 Improved purification and yields of RNA by RNeasy. Biotechniques 21:57-60
52. Song K, Wang H, Krebs TL, Danielpour D 2006 Novel roles of Akt and mTOR in suppressing TGF-β/ALK5-mediated Smad3 activation. EMBO J 25:58-69 (Pubitemid 43077295)